Cardiac Rhythm Management Devices – Market Insights – Europe

The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased adoption of premium-priced devices such as CRT devices, single-chamber leadless pacemakers, and extravascular ICDs. However, revenue growth will be limited by ASP declines driven by increasing competition in the leadless pacemaker and extravascular ICD markets.

This Medtech 360 Report provides comprehensive data and analysis on the state of the European CRM device market from 2019 through 2035.

The highly saturated CRM device market will drive competitors to focus on innovation as a key strategy for growth.

Which segments are saturated, and which segments continue to see dynamic growth?

How do epidemiological trends and new technology influence growth in different pulse generator product segments?

How can individual competitors realize growth in this large but fairly mature market?

Will mergers and acquisitions play a key role in this device market?

The emergence of CSP is reshaping clinical practice and device adoption trends in the CRM device market.

Which CRM device segments are most affected by CSP adoption?

To what extent are the clinical benefits of CSP compared with traditional pacing approaches driving shifts in procedure mix?

How is growing interest in CSP expected to influence longerterm market dynamics for established pacing technologies?

Adoption of novel devices will offset waning revenue for traditional devices in the European CRM market.

What is the predicted uptake of novel devices such as leadless pacemakers and extravascular ICDs? Will leadless pacemakers and extravascular ICDs become the standard of care?

To what extent will the uptake of leadless pacemakers and extravascular ICDs offset declining revenue in other markets?

How will the availability and increasing clinical adoption of dual-chamber leadless pacemakers impact the traditional dual-chamber pacemaker market?

How are evolving clinical evidence and innovation-driven competition shaping the European CRM device market?

How will robust clinical data generation influence physician adoption, reimbursement decisions, and uptake of disruptive CRM devices?

How will ongoing clinical trials impact competitive positioning and segment-level market share dynamics?

How will the adoption of novel devices, including leadless pacemakers and extravascular ICDs, reshape the competitive landscape and future growth strategies?